France: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in France

The French medicaments containing insulin market was finally on the rise to reach $X in 2022, after two years of decline. In general, consumption, however, continues to indicate a relatively flat trend pattern. Medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Medicaments Containing Insulin Production in France

In value terms, medicaments containing insulin production amounted to $X in 2022 estimated in export price. Over the period under review, production, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 when the production volume increased by X%. As a result, production attained the peak level of $X. From 2014 to 2022, production growth remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from France

In 2022, exports of medicaments containing insulin but not antibiotics from France declined rapidly to X kg, which is down by X% against the previous year. Over the period under review, exports, however, recorded a resilient increase. The most prominent rate of growth was recorded in 2020 with an increase of X%. As a result, the exports attained the peak of X tons. From 2021 to 2022, the growth of the exports remained at a lower figure.

In value terms, medicaments containing insulin exports declined remarkably to $X in 2022. In general, exports, however, posted strong growth. The most prominent rate of growth was recorded in 2020 when exports increased by X%. As a result, the exports attained the peak of $X. From 2021 to 2022, the growth of the exports remained at a somewhat lower figure.

Exports by Country

New Caledonia (X kg), French Polynesia (X kg) and Gabon (X kg) were the main destinations of medicaments containing insulin exports from France, together accounting for X% of total exports.

From 2012 to 2022, the biggest increases were recorded for New Caledonia (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest markets for medicaments containing insulin exported from France were New Caledonia ($X), French Polynesia ($X) and Gabon ($X), together comprising X% of total exports.

In terms of the main countries of destination, New Caledonia, with a CAGR of X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2022, shrinking by X% against the previous year. Overall, the export price showed a noticeable descent. The pace of growth was the most pronounced in 2016 when the average export price increased by X%. The export price peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was New Caledonia ($X per ton), while the average price for exports to Benin ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to French Polynesia (X%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Insulin Imports

Imports into France

In 2022, after two years of decline, there was growth in overseas purchases of medicaments containing insulin but not antibiotics, when their volume increased by X% to X kg. In general, imports, however, saw a slight curtailment. The most prominent rate of growth was recorded in 2018 with an increase of X,100% against the previous year. Over the period under review, imports attained the maximum at X tons in 2019; however, from 2020 to 2022, imports stood at a somewhat lower figure.

In value terms, medicaments containing insulin imports totaled $X in 2022. Over the period under review, imports enjoyed a remarkable increase. The most prominent rate of growth was recorded in 2018 when imports increased by X,842%. Over the period under review, imports attained the maximum at $X in 2019; however, from 2020 to 2022, imports remained at a lower figure.

Imports by Country

In 2022, Italy (X kg) was the main supplier of medicaments containing insulin to France, with a X% share of total imports. It was followed by the United States (X kg), with a X% share of total imports.

From 2012 to 2022, the average annual growth rate of volume from Italy totaled X%.

In value terms, Italy ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to France, comprising X% of total imports. The second position in the ranking was held by the United States ($X), with a X% share of total imports.

From 2012 to 2022, the average annual rate of growth in terms of value from Italy amounted to X%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2022, reducing by X% against the previous year. Over the period under review, the import price, however, saw resilient growth. The most prominent rate of growth was recorded in 2021 when the average import price increased by X%. As a result, import price attained the peak level of $X per ton, and then dropped slightly in the following year.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Italy ($X per ton), while the price for the United States stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :